Mario Badescu Skin Care, a leading manufacturer of skin care and acne treatment products, as well as operator of a 36 room Manhattan beauty salon, has launched a new website with updated usability features in order to make their customers' skin care shopping experience as easy and enjoyable as possible.
Mario Badescu Skin Care Logo
We are very excited about the launch of these new website features
The efforts of our skilled and dedicated team to design and implement these features are all part of our larger attempt to better serve our customers. It is our first priority to make our customers' shopping experiences more pleasant and efficient, and to better serve them with personalized skin care advice and product recommendations.
The new website, which launched Tuesday, features a new look and feel, as well as increased organization, allowing shoppers to view their selection of over 200 skin care products in a neat and efficient manner. In addition to the updated appearance and organization, several functional changes have been made to increase the usability of the website, including convenient one-click add to shopping cart functionality.
The website also incorporates a new Wishlist functionality, allowing users to browse around Mario Badescu's extensive line of skin care and acne treatment products and select products that they may be interested in purchasing in the future.
These new changes are just a few in a series of initiatives to bolster the customer shopping experience. Mario Badescu's existing MyMario feature, for example, allows shoppers to view their past orders, as well as personalized skin care product recommendations. This allows customers to build an optimal skin care regimen to treat their specific skin type or get rid of acne.
Mario Badescu is hoping to use these new website features to continue their tradition of offering customers their famous skin care and acne treatment products, which are renowned as much for their quality and effectiveness as their celebrity use.
"We are very excited about the launch of these new website features," said Joseph Cabasso, Executive Vice President of Mario Badescu Skin Care. "The efforts of our skilled and dedicated team to design and implement these features are all part of our larger attempt to better serve our customers. It is our first priority to make our customers' shopping experiences more pleasant and efficient, and to better serve them with personalized skin care advice and product recommendations."
Source: http://www.prweb.com/releases/skin_care/acne_treatment_products/prweb2450344.htm
Thursday, May 28, 2009
Tuesday, May 19, 2009
Rated Beast Acne Treatment Product
Acnezine solution has been scientifically tested and is proven to give you 100% results. Adolescents, adults and everyone irrespective of their age can use this acne treatment product. It can safely be used to cure facial acne or acne in any other part of the body. Acne can be used on pimples, blackheads, whiteheads and it effectively reduces spots and redness of the acne prone skin. It completely dries the acne and leaves no trace of it. The best bet is that the formulation is completely free from side effects.
Recommended by Top Dermatologists
Impurities and imbalances within the body give rise to acne. The skin should be kept oil and dirt free to get rid of acne. It is therefore that this acne treatment product works by cleansing the acne prone area. It acts skin deep and helps to cure acne from within the skin. Acnezine is rich in anti-oxidants, which capture the harmful free radicals from deep inside the skin. Its anti-oxidant property also helps in treating ageing and skin blemishes. Acnezine also helps to relax the otherwise inflamed and irritated skin and speeds up the healing process.
Acnezine is a wonder drug and is known to have given satisfactory results to all the people who have tried it. Acne can bring in a lot of discomfort in the lives of people. Acnezine not only combats acne problems but also brings back the confidence on your face. If you have tried almost everything under the sun to get rid of acne and with vain, then you will be surprised at the easiness with which Acnezine works. And you get all this without any known side effect as this acne treatment product is completely natural!
Source: http://www.msokorea.com/acne/0,6600,385780,00.html
Recommended by Top Dermatologists
Impurities and imbalances within the body give rise to acne. The skin should be kept oil and dirt free to get rid of acne. It is therefore that this acne treatment product works by cleansing the acne prone area. It acts skin deep and helps to cure acne from within the skin. Acnezine is rich in anti-oxidants, which capture the harmful free radicals from deep inside the skin. Its anti-oxidant property also helps in treating ageing and skin blemishes. Acnezine also helps to relax the otherwise inflamed and irritated skin and speeds up the healing process.
Acnezine is a wonder drug and is known to have given satisfactory results to all the people who have tried it. Acne can bring in a lot of discomfort in the lives of people. Acnezine not only combats acne problems but also brings back the confidence on your face. If you have tried almost everything under the sun to get rid of acne and with vain, then you will be surprised at the easiness with which Acnezine works. And you get all this without any known side effect as this acne treatment product is completely natural!
Source: http://www.msokorea.com/acne/0,6600,385780,00.html
Tuesday, May 12, 2009
Botox Maker Allergan Faces Nestle-L’Oreal Challenge in Europe
Botox faces its greatest challenge in the market to wipe the wrinkles off European foreheads when a Nestle SA-L’Oreal SA joint venture starts selling its own injectable skin treatment next month.
Azzalure, as the new product is known, will go on sale in the U.K. in “coming days,” said Francois Fournier, who heads L’Oreal and Nestle’s Galderma venture in Europe. France will follow, and Galderma aims to sell the treatment in all of Europe’s main markets by the end of 2009, he said in an interview at his Lausanne, Switzerland office last week.
Botox, made by Allergan Inc. from a purified form of a deadly poison, has had few challengers since the 1990s, when doctors started using it to treat wrinkles. Sales last year were $1.3 billion, and the drug controlled 83 percent of the global market for neurotoxins that paralyze certain muscles or nerves, aiming to give patients a more youthful appearance.
Ipsen SA, the French drugmaker that granted Galderma the distribution rights for Azzalure, wants a piece of the action, and on April 30 got approval for sale of the treatment in the U.S. under the brand Dysport.
Competition in the U.S. and Europe “combined is going to put a dent in Allergan’s market share,” said Peter Bye, an analyst at Jefferies Group Inc. with a “hold” rating on the U.S. company’s stock. Azzalure is “a bit more of a threat.” He said Botox may lose 4 percentage points of market share in 2009.
L’Oreal, the world’s biggest cosmetics maker, teamed up with Nestle, one of its biggest shareholders, to create Galderma as a prescription skin-treatment business in 1981. The world’s biggest food company has said Galderma joined Hot Pockets sandwiches and Buitoni pasta among 29 Nestle brands with revenue exceeding 1 billion Swiss francs ($880 million) last year.
Full Story: http://www.bloomberg.com/apps/news?pid=20601100&sid=aoETYzMjS.Zc&refer=germany
Azzalure, as the new product is known, will go on sale in the U.K. in “coming days,” said Francois Fournier, who heads L’Oreal and Nestle’s Galderma venture in Europe. France will follow, and Galderma aims to sell the treatment in all of Europe’s main markets by the end of 2009, he said in an interview at his Lausanne, Switzerland office last week.
Botox, made by Allergan Inc. from a purified form of a deadly poison, has had few challengers since the 1990s, when doctors started using it to treat wrinkles. Sales last year were $1.3 billion, and the drug controlled 83 percent of the global market for neurotoxins that paralyze certain muscles or nerves, aiming to give patients a more youthful appearance.
Ipsen SA, the French drugmaker that granted Galderma the distribution rights for Azzalure, wants a piece of the action, and on April 30 got approval for sale of the treatment in the U.S. under the brand Dysport.
Competition in the U.S. and Europe “combined is going to put a dent in Allergan’s market share,” said Peter Bye, an analyst at Jefferies Group Inc. with a “hold” rating on the U.S. company’s stock. Azzalure is “a bit more of a threat.” He said Botox may lose 4 percentage points of market share in 2009.
L’Oreal, the world’s biggest cosmetics maker, teamed up with Nestle, one of its biggest shareholders, to create Galderma as a prescription skin-treatment business in 1981. The world’s biggest food company has said Galderma joined Hot Pockets sandwiches and Buitoni pasta among 29 Nestle brands with revenue exceeding 1 billion Swiss francs ($880 million) last year.
Full Story: http://www.bloomberg.com/apps/news?pid=20601100&sid=aoETYzMjS.Zc&refer=germany
Monday, May 4, 2009
New generics
Zydus announced that it has received final FDA approval for its Abbreviated New Drug Application (ANDA) for Topiramate Tablets USP, 25 mg, 50 mg, 100 mg, and 200 mg. Topiramate tablets are the generic version of Ortho-McNeil-Janssen's Topamax Tablets.
Ranbaxy announced the FDA has approved its ANDA to market and manufacture Ramipril Capsules 5 mg and 10 mg. The FDA had determined the Ranbaxy formulations to be bioequivalent and as having the same therapeutic effect as that of the reference-listed drug, Altace, by King.
Teva announced the FDA granted final approval of its ANDA to market Minocycline HCl Capsules, its generic version of Medicis' acne treatment Solodyn Extended-Release Tablets, 45 mg, 90 mg, and 135 mg.
Ranbaxy announced that it has received an approval from the FDA for its ANDA for Quinapril + HCTZ Tablets (quinapril hydrochloride and hydrochlorothiazide), 10 mg/12.5 mg, 20 mg/12.5 mg, and 20mg/25mg. The FDA determined the Ranbaxy formulations to be bioequivalent and as having the same therapeutic effect as that of the reference-listed drug, Pfizer's Accuretic Tablets.
Full Coverage: http://www.modernmedicine.com/modernmedicine/Over+the+Counter/New-products-Rx-generic-OTC-May-2009/ArticleStandard/Article/detail/596058?contextCategoryId=40159
Ranbaxy announced the FDA has approved its ANDA to market and manufacture Ramipril Capsules 5 mg and 10 mg. The FDA had determined the Ranbaxy formulations to be bioequivalent and as having the same therapeutic effect as that of the reference-listed drug, Altace, by King.
Teva announced the FDA granted final approval of its ANDA to market Minocycline HCl Capsules, its generic version of Medicis' acne treatment Solodyn Extended-Release Tablets, 45 mg, 90 mg, and 135 mg.
Ranbaxy announced that it has received an approval from the FDA for its ANDA for Quinapril + HCTZ Tablets (quinapril hydrochloride and hydrochlorothiazide), 10 mg/12.5 mg, 20 mg/12.5 mg, and 20mg/25mg. The FDA determined the Ranbaxy formulations to be bioequivalent and as having the same therapeutic effect as that of the reference-listed drug, Pfizer's Accuretic Tablets.
Full Coverage: http://www.modernmedicine.com/modernmedicine/Over+the+Counter/New-products-Rx-generic-OTC-May-2009/ArticleStandard/Article/detail/596058?contextCategoryId=40159
Subscribe to:
Posts (Atom)
